07.12.2012 Views

Chromosome segregation errors: a double-edged sword - TI Pharma

Chromosome segregation errors: a double-edged sword - TI Pharma

Chromosome segregation errors: a double-edged sword - TI Pharma

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

treatment respectively. In line with these data, C26 cells also showed a significant increase in CFP/<br />

YFP ratio following docetaxel treatment (a ratio of 1.0 before and 1.3 and 1.7 after 20 and 48 hours<br />

of docetaxel treatment respectively) (Fig.3B). To confirm our FRET results, we also performed<br />

fluorescence lifetime imaging microscopy (FLIM) (Fig.3C). Caspase-3 activation results in loss of<br />

FRET due to cleavage of the DEVD motif (Fig.2A) and therefore should cause an increase in the CFP<br />

fluorescence lifetime 610 . In line with our CFP/YFP ratio measurements, FLIM analysis of C26 cells after<br />

docetaxel treatment revealed a significant increase in CFP lifetime from, on average, 1.3 ns before<br />

docetaxel treatment to 1.8 ns at two days after docetaxel treatment (Fig.3C, D). The observed increase<br />

in caspase-3 activity was not caused by insertion of the imaging window or by light exposure during<br />

imaging, since FLIM analysis of tumor sections from within the tumor (not reached by either the<br />

window or the laser beam) showed that FRET was even more frequently lost in these areas (Fig.S2A).<br />

Together, these data show that caspase-3 activity, and therefore the onset of apoptosis, is induced<br />

upon treatment with docetaxel both in vitro and in vivo.<br />

A In vitro B<br />

In vivo<br />

7<br />

6<br />

5<br />

4<br />

6<br />

SW480<br />

*<br />

*<br />

*<br />

3<br />

2<br />

4<br />

1<br />

2<br />

0<br />

-<br />

0<br />

+<br />

16<br />

+<br />

24<br />

+<br />

24*<br />

Docetaxel<br />

hours<br />

0<br />

Before Day1 Day2<br />

After Dtx<br />

C C26<br />

25mg/kg Dtx: D<br />

CFP/YFP ratio<br />

Increase in CFP-Fluoresc.<br />

Lifetime<br />

1.25 ns<br />

Alive<br />

2.5 ns<br />

Dead<br />

CFP/YFP ratio<br />

-<br />

+<br />

Fluorescence Lifetime (nsec)<br />

Figure 3. Docetaxel increases caspase-3 activity in vitro and in vivo<br />

A) Quantification of the CFP-YFP ratio of SW480 cells in vitro under indicated conditions. 24* indicates that only apoptotic cells<br />

were analyzed, in all other cases (0, 16, 24) mitotic cells were quantified. Apoptotic and mitotic cells were determined according<br />

to morphology. Apoptotic: membrane blebbing, fragmented DNA. Mitotic: condensed DNA, rounded membrane morphology.<br />

10 cells were quantified per condition. Average + SEM is shown. B) Quantification of CFP-YFP ratios in single cells in vivo of the<br />

same tumor fields before, 20 hours (day1) and 48 hours (day2) after 25mg/kg docetaxel treatment (SW480-left, C26-right).<br />

Representative experiment of 3 independent experiments per cell line is shown. One dot represents one cell. Line indicates average<br />

+ SD. n.s.: not-significant (student t-test, paired, P>0.05), *: significant (student t-test, unpaired, p0.05), *: significant (student<br />

t-test, unpaired, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!